Iomeron

Iomeprol, the active ingredient in Iomeron, is a iodinated contrast media presented as a solution for injection for intraarterial, intraarticular, and intravenous use. It enhances radiographic visualization of vascular and joint spaces during diagnostic imaging procedures.

GNH USA supplies Iomeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Iomeron (iomeprol) is an iodinated contrast agent used in diagnostic imaging to improve visualization of vascular and joint structures.

- Angiography: provides enhanced contrast of blood vessels to delineate vascular anatomy. - Arthrography: improves joint space imaging for assessment of intra‑articular structures. - CT imaging: increases radiodensity of tissues, allowing clearer cross‑sectional images.

Iomeron may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea or vomiting. - Warm or flushing sensation. - Metallic taste. - Mild headache.

Serious or Rare Side Effects: - Anaphylactic reaction. - Acute kidney injury. - Severe hypotension or cardiovascular collapse.

Before administering Iomeron, consider the following precautions. - Assess renal function: evaluate creatinine clearance to reduce risk of nephrotoxicity. - Screen for iodine allergy: avoid use in patients with known hypersensitivity to iodinated contrast. - Use the lowest effective dose: limit iodine exposure while achieving diagnostic quality. - Monitor vital signs during injection: watch for immediate hypersensitivity or hemodynamic changes. - Avoid in patients with severe hyperthyroidism: iodine load may exacerbate thyroid activity. - Store at ambient temperature: keep in the original container, protect from light and moisture.

Iomeron can interact with other agents that affect renal function or iodine handling.

Major Interactions (Avoid): - Concurrent use of other iodinated contrast agents: cumulative iodine load increases toxicity risk. - High‑dose nephrotoxic drugs (e.g., aminoglycosides): may amplify renal impairment. - Radioactive iodine therapy: interferes with thyroid iodine uptake.

Moderate Interactions (Monitor Closely): - Diuretics: may alter renal clearance of the contrast medium. - Metformin: risk of lactic acidosis in patients with reduced renal function after contrast exposure.